Literature DB >> 7489941

Colitis and colonic mucosal barrier dysfunction.

K R Gardiner1, N H Anderson, B J Rowlands, A Barbul.   

Abstract

Trauma, infection, neoplasia, and inflammation can all disrupt the intact intestinal mucosal barrier to intraluminal bacteria and bacterial antigens. This study investigated the relation between colonic inflammation and colonic mucosal barrier function in three experimental models of colitis. There were significantly increased systemic endotoxin concentrations in rats with acetic acid (7.5 (1.7-119.5) pg/ml), ethanol (13.7 (0-111.2) pg/ml), and hapten induced (14.4 (5-31.1) pg/ml) colitis compared with saline controls (3.3 (0-13.7) pg/ml). Data expressed as median (range). There were significant correlations between the systemic endotoxin concentration and both the severity of colitis and of illness in acetic acid induced colitis. A significant increase in colonic permeability to 14C-polyethylene glycol was shown in rats with acetic acid (3.42 (1.36-5.63)%) and hapten induced colitis (2.86 (1.03-8.10)%) compared with saline controls (1.20 (0.67-1.36)%). Data expressed as median (range) of percentage of the intracolonic bolus excreted in urine. There was a significant positive correlation between the severity of colitis and % colonic permeability to 14C-polyethylene glycol. This and other studies provide evidence that mucosal barrier dysfunction is a feature of colitis irrespective of aetiology or species. Such barrier dysfunction may be responsible for the systemic inflammatory response and complications seen in patients with inflammatory bowel disease.

Entities:  

Mesh:

Substances:

Year:  1995        PMID: 7489941      PMCID: PMC1382906          DOI: 10.1136/gut.37.4.530

Source DB:  PubMed          Journal:  Gut        ISSN: 0017-5749            Impact factor:   23.059


  41 in total

1.  A study of endotoxemia in ulcerative colitis and Crohn's disease. I. Clinical study.

Authors:  K Aoki
Journal:  Acta Med Okayama       Date:  1978-06       Impact factor: 0.892

2.  Measurements of intestinal permeability using low molecular weight polyethylene glycols (PEG 400). I. Chemical analysis and biological properties of PEG 400.

Authors:  V S Chadwick; S F Phillips; A F Hofmann
Journal:  Gastroenterology       Date:  1977-08       Impact factor: 22.682

3.  Influence of inflammatory bowel disease on intestinal microflora.

Authors:  M R Keighley; Y Arabi; F Dimock; D W Burdon; R N Allan; J Alexander-Williams
Journal:  Gut       Date:  1978-12       Impact factor: 23.059

4.  [Detection of endotoxemia in patients with cryptogenic inflammatory enterocolitis].

Authors:  R Colin; T Grancher; J F Lemeland; P Hecketsweiler; J P Galmiche; A Le Grix; Y Geffroy
Journal:  Gastroenterol Clin Biol       Date:  1979-01

5.  Significance of systemic endotoxaemia in inflammatory bowel disease.

Authors:  K R Gardiner; M I Halliday; G R Barclay; L Milne; D Brown; S Stephens; R J Maxwell; B J Rowlands
Journal:  Gut       Date:  1995-06       Impact factor: 23.059

6.  A study of endotoxemia in ulcerative colitis and Crohn's disease. II. Experimental study.

Authors:  K Aoki
Journal:  Acta Med Okayama       Date:  1978-07       Impact factor: 0.892

7.  Translocation of certain indigenous bacteria from the gastrointestinal tract to the mesenteric lymph nodes and other organs in a gnotobiotic mouse model.

Authors:  R D Berg; A W Garlington
Journal:  Infect Immun       Date:  1979-02       Impact factor: 3.441

8.  Increased incidence of faecal coliforms with in vitro adhesive and invasive properties in patients with ulcerative colitis.

Authors:  R J Dickinson; S A Varian; A T Axon; E M Cooke
Journal:  Gut       Date:  1980-09       Impact factor: 23.059

9.  Agglutinins to bacteria in Crohn's disease.

Authors:  N Matthews; J F Mayberry; J Rhodes; L Neale; J Munro; F Wensinck; G H Lawson; A C Rowland; G A Berkhoff; S W Barthold
Journal:  Gut       Date:  1980-05       Impact factor: 23.059

10.  Effect of molecular structure on bile acid-induced alterations in absorptive function, permeability, and morphology in the perfused rabbit colon.

Authors:  V S Chadwick; T S Gaginella; G L Carlson; J C Debongnie; S F Phillips; A F Hofmann
Journal:  J Lab Clin Med       Date:  1979-11
View more
  14 in total

1.  Carbonylation and disassembly of the F-actin cytoskeleton in oxidant induced barrier dysfunction and its prevention by epidermal growth factor and transforming growth factor alpha in a human colonic cell line.

Authors:  A Banan; Y Zhang; J Losurdo; A Keshavarzian
Journal:  Gut       Date:  2000-06       Impact factor: 23.059

2.  Increases in free radicals and cytoskeletal protein oxidation and nitration in the colon of patients with inflammatory bowel disease.

Authors:  A Keshavarzian; A Banan; A Farhadi; S Komanduri; E Mutlu; Y Zhang; J Z Fields
Journal:  Gut       Date:  2003-05       Impact factor: 23.059

3.  Polyethylene glycol enhances colonic barrier function and ameliorates experimental colitis in rats.

Authors:  Sebastián Videla; Aurelia Lugea; Jaime Vilaseca; Francisco Guarner; Francesc Treserra; Antonio Salas; Ernesto Crespo; Carlos Medina; Juan R Malagelada
Journal:  Int J Colorectal Dis       Date:  2006-10-24       Impact factor: 2.571

4.  Differences in the reducing power along the rat GI tract: lower antioxidant capacity of the colon.

Authors:  S Blau; A Rubinstein; P Bass; C Singaram; R Kohen
Journal:  Mol Cell Biochem       Date:  1999-04       Impact factor: 3.396

5.  Surface hydrophobicity of the rat colonic mucosa is a defensive barrier against macromolecules and toxins.

Authors:  A Lugea; A Salas; J Casalot; F Guarner; J R Malagelada
Journal:  Gut       Date:  2000-04       Impact factor: 23.059

6.  Increased exposure to bacterial antigen RpL7/L12 in early stage colorectal cancer patients.

Authors:  Annemarie Boleij; Rian Roelofs; Renée M J Schaeps; Tanja Schülin; Philippe Glaser; Dorine W Swinkels; Ikuko Kato; Harold Tjalsma
Journal:  Cancer       Date:  2010-09-01       Impact factor: 6.860

7.  T cell specificity and cross reactivity towards enterobacteria, bacteroides, bifidobacterium, and antigens from resident intestinal flora in humans.

Authors:  R Duchmann; E May; M Heike; P Knolle; M Neurath; K H Meyer zum Büschenfelde
Journal:  Gut       Date:  1999-06       Impact factor: 23.059

8.  Short-chain inulin-like fructans reduce endotoxin and bacterial translocations and attenuate development of TNBS-induced colitis in rats.

Authors:  Hiroyuki Ito; Hiroki Tanabe; Hirokazu Kawagishi; Wada Tadashi; Tomono Yasuhiko; Kimio Sugiyama; Shuhachi Kiriyama; Tatsuya Morita
Journal:  Dig Dis Sci       Date:  2008-12-03       Impact factor: 3.199

9.  Modulation of the effect of dextran sulfate sodium-induced acute colitis by the administration of different probiotic strains of Lactobacillus and Bifidobacterium.

Authors:  Nadia Osman; Diya Adawi; Siv Ahrne; Bengt Jeppsson; Göran Molin
Journal:  Dig Dis Sci       Date:  2004-02       Impact factor: 3.199

10.  CD4+ T cells from 2,4,6-trinitrobenzene sulfonic acid (TNBS)-induced colitis rodents migrate to the recipient's colon upon transfer; down-regulation by CD8+ T cells.

Authors:  M J Palmen; O L Wijburg; I H Kunst; H Kroes; E P van Rees
Journal:  Clin Exp Immunol       Date:  1998-05       Impact factor: 4.330

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.